Increase in insulin action and fat oxidation after treatment with CL 316,243, a highly selective beta3-adrenoceptor agonist in humans. - Weyer,C.; Tataranni,P.; Snitker,S.; Danforth,E.; Ravussin,E. (Diabetes, 1998)